Ethan Perlstein - Concepedia

Author

Ethan Perlstein

Howard Hughes Medical Institute ORCID

Also Known As

E. O. Perlstein, Ethan O Perlstein, Ethan O. Perlstein, Ethan Perlstein, Perlstein, Ethan

101

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Howard Hughes Medical Institute Broad Institute Harvard University Princeton University Mayo Clinic

About

Ethan Perlstein is an author at Howard Hughes Medical Institute specializing in medicine, genetics, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.1K
2	Natural Sciences	4	4	287
3	Engineering	2	2	29
4	Health Sciences	2	2	86
5	Public Health	1	1	11

Ethan Perlstein

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models Sovan Sarkar, Ethan Perlstein, Sara Imarisio, Nature Chemical Biology Disease ModelsMitophagyCell AutophagyAutophagyCell Death	2007	603
Global nucleosome occupancy in yeast B Bernstein, Chih Long Liu, Emily L Humphrey, Genome biology	2004	355
A Library of Spirooxindoles Based on a Stereoselective Three-Component Coupling Reaction Michael M.‐C. Lo, Christopher S. Neumann, Satoshi Nagayama, Journal of the American Chemical Society	2004	271
Small Molecule Enhancers of Rapamycin-Induced TOR Inhibition Promote Autophagy, Reduce Toxicity in Huntington’s Disease Models and Enhance Killing of Mycobacteria by Macrophages R. Andrés Floto, Sovan Sarkar, Ethan Perlstein, Autophagy	2007	158
Genetic basis of individual differences in the response to small-molecule drugs in yeast Ethan Perlstein, Douglas M. Ruderfer, David Roberts, Nature Genetics Drug TargetNatural SciencesGeneticsIndividual DifferencesMolecular Biology	2007	133
Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway Rebecca A. Butcher, Bhupinder Bhullar, Ethan Perlstein, Nature Chemical Biology Functional GenomicsTor PathwayGeneticsNatural SciencesComputational Biology	2006	99
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG Sangeetha Iyer, Feba S. Sam, Nina DiPrimio, Disease Models & Mechanisms	2019	78
Harnessing gene expression to identify the genetic basis of drug resistance Bo‐Juen Chen, Helen C. Causton, Denesy Mancenido, Molecular Systems Biology	2009	55
The Antidepressant Sertraline Targets Intracellular Vesiculogenic Membranes in Yeast Meredith M. Rainey, Daniel Korostyshevsky, Sean Bong Lee, Genetics	2010	54
Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic Implications Anna N. Ligezka, Silvia Radenkovic, Mayank Saraswat, Annals of Neurology Glycosylation BiomarkersImmunologyGlycobiologyPathologyImmunotherapy	2021	54

Page 1